TRIM14 and glioblastoma: It has been shown that TRIM14 can up-regulate and interact with Dvl2 to activate the Wnt/β-catenin signaling pathway, which in turn up-regulates MGMT capable of effectively reversing alkylation-induced DNA damage to promote TMZ resistance in GBM cells [42–44].